Find your Enbioma expert

AI-Designed nutraceutical formulations

Powered by AI-driven microbiome simulation, we are building a scalable product platform across disease and wellness areas.
Our first product for Dry Eye passed the clinical trials successfully. Further multiple solutions across emerging health categories are currently in development and to be launched in Q3 & Q4 2026
Discover

The ENBIOSIS
Technology

The ENBIOSIS Technology

ENBIOSIS is a biotechnology company developing next-generation health products through AI-driven microbiome science.

Our technology enables the design of targeted, food-derived formulations that support the body’s own biological pathways across multiple disease and wellness areas.

A scalable product vision

Our platform is designed to address a wide range of microbiome-linked conditions and wellness needs, from chronic diseases to daily health optimization.

Eye Health & Dry Eye Support

Clinical Trial: completed
Product launch date: April 2026

Hormonal Conditions

Clinical Trial: in progress
Product launch date: April 2026

Digestive Disorders (IBS/IBD)

Clinical Trial: in progress
Product launch date: May 2026

Weight Management & GLP-1 Support

Clinical Trial: planned for June 2026
Product launch date: September 2026

Neurological Conditions

Clinical Trial: planned for August 2026
Product launch date: October 2026

Sexual Health

Clinical Trial: planned for April 2026
Product launch date: July 2026

Urological Conditions

Clinical Trial: planned for November 2026
Product launch date: March 2027

Mental Health

Clinical Trial: planned for December 2026
Product launch date: April 2027

Longevity & Cellular Health

Clinical Trial: planned for February 2027
Product launch date: June 2027

Our first product: Dry Eye

Dry Eye was selected as the initial model indication due to its strong microbiome connection and clear clinical endpoints.

The product is designed to support tear production and ocular surface health by guiding microbiome-driven molecular pathways, ddressing the condition from within.

Seamless integration into our product portfolio

Our formulations are engineered exclusively for B2B scale. We deliver highly stable, standardized powder premixes that integrate flawlessly into your existing supply chain.

Transform our AI formulations into capsules, soluble sachets or functional food bars under your own brand name.

Secure your supply of AI-formulated premixes

ENBIOSIS is building a growing pipeline of microbiome-driven products across multiple disease and wellness areas.

Our technology, formulations, and clinical programs are progressing in parallel with creating long-term opportunities for strategic partners and investors.

Want to partner with us or get early access to our products? Get in touch with our experts to request samples, clinical data or to discuss other topics.

Learn more about our partnership models and how you can benefit from the ENBIOSIS technology.
Get in touch
Please select the partner in your region to get your microbome analysis.
[region_country_table]
Your country is not listed? If interested to become a partner to spread this new health technology in your region please click here.
For other issues feel free to contact our Support.
Find your Enbiosis expert
Register your kit
Partners
Laboratories Clinics & medical centers Telehealth Pharmacies